126 related articles for article (PubMed ID: 4010945)
1. Plasmalogen analysis in erythrocyte membranes of adrenoleukodystrophy.
Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
Neurology; 1985 Jul; 35(7):1051-3. PubMed ID: 4010945
[TBL] [Abstract][Full Text] [Related]
2. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
[TBL] [Abstract][Full Text] [Related]
3. Plasmalogen deficiency in cultured skin fibroblasts from neonatal adrenoleukodystrophy.
Sakai T; Antoku Y; Goto I
Exp Neurol; 1986 Oct; 94(1):149-54. PubMed ID: 3758277
[TBL] [Abstract][Full Text] [Related]
4. Stereological analysis of peroxisomes and mitochondria in intestinal epithelium of patients with peroxisomal deficiency disorders: Zellweger's syndrome and neonatal-onset adrenoleukodystrophy.
Black VH; Cornacchia L
Am J Anat; 1986 Sep; 177(1):107-18. PubMed ID: 3776884
[TBL] [Abstract][Full Text] [Related]
5. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
6. Adrenoleukodystrophy: abnormality of "tightly bound" fatty acids in the erythrocyte membrane proteins.
Antoku Y; Sakai T; Goto I; Miyoshino S; Iwashita H; Kuroiwa Y
Neurology; 1985 Oct; 35(10):1512-4. PubMed ID: 4033936
[TBL] [Abstract][Full Text] [Related]
7. Analysis of very long-chain fatty acids and plasmalogen in the erythrocyte membrane: a simple method for the detection of peroxisomal disorders and discrimination between adrenoleukodystrophy and Zellweger syndrome.
Tanaka K; Nishizawa K; Yamamoto H; Naruto T; Izeki E; Taga T; Shimada M; Saeki Y
Neuropediatrics; 1990 Aug; 21(3):119-23. PubMed ID: 2234315
[TBL] [Abstract][Full Text] [Related]
8. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
9. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
[TBL] [Abstract][Full Text] [Related]
10. Ocular histopathologic and biochemical studies of the cerebrohepatorenal syndrome (Zellweger's syndrome) and its relationship to neonatal adrenoleukodystrophy.
Cohen SM; Brown FR; Martyn L; Moser HW; Chen W; Kistenmacher M; Punnett H; de la Cruz ZC; Chan NR; Green WR
Am J Ophthalmol; 1983 Oct; 96(4):488-501. PubMed ID: 6624831
[TBL] [Abstract][Full Text] [Related]
11. Neonatal adrenoleukodystrophy. Impaired plasmalogen biosynthesis and peroxisomal beta-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts.
Wanders RJ; Schutgens RB; Schrakamp G; Tager JM; Van den Bosch H; Moser AB; Moser HW
J Neurol Sci; 1987 Feb; 77(2-3):331-40. PubMed ID: 3819771
[TBL] [Abstract][Full Text] [Related]
12. Very long-chain fatty acids in erythrocyte membrane phospholipids in adrenoleukodystrophy.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Nishizawa K; Saeki Y
Acta Paediatr Jpn; 1989 Apr; 31(2):136-43. PubMed ID: 2516693
[TBL] [Abstract][Full Text] [Related]
13. Adrenoleukodystrophy: fatty acid analysis of total glycerophospholipids in erythrocyte membranes.
Antoku Y; Sakai T; Goto I; Katafuchi Y; Sato H; Iwashita H; Kuroiwa Y
Acta Neurol Scand; 1985 Aug; 72(2):193-7. PubMed ID: 4050328
[TBL] [Abstract][Full Text] [Related]
14. Essential fatty acids and serine as plasmalogen precursors in relation to competing metabolic pathways.
Cook HW; Thomas SE; Xu Z
Biochem Cell Biol; 1991 Jul; 69(7):475-84. PubMed ID: 1793558
[TBL] [Abstract][Full Text] [Related]
15. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
[TBL] [Abstract][Full Text] [Related]
16. Dietary treatment of adrenoleukodystrophy.
Suzuki S; Kobayashi T; Goto I; Kuroiwa Y
Neurology; 1986 Jan; 36(1):104-6. PubMed ID: 3941763
[TBL] [Abstract][Full Text] [Related]
17. Polarizing inclusions in some organs of children with congenital peroxisomal diseases (Zellweger's, Refsum's, chondrodysplasia punctata (rhizomelic form), X-linked adrenoleukodystrophy).
Kerckaert I; Dingemans KP; Heymans HS; Vamecq J; Roels F
J Inherit Metab Dis; 1988; 11(4):372-86. PubMed ID: 2468818
[TBL] [Abstract][Full Text] [Related]
18. Impaired ability of peroxisomes to activate very-long-chain fatty acids in X-linked adrenoleukodystrophy.
Wanders RJ; van Roermund CW; Schutgens RB; van den Bosch H; Tager JM
Lancet; 1988 Jul; 2(8603):170. PubMed ID: 2899227
[No Abstract] [Full Text] [Related]
19. [Peroxisomal disorders; newer concept and recent studies].
Kamoshita S
Nihon Rinsho; 1990 Mar; 48(3):629-38. PubMed ID: 2192101
[No Abstract] [Full Text] [Related]
20. A study on erythrocyte membrane plasmalogen in myotonic dystrophy.
Antoku Y; Sakai T; Tsukamoto K; Goto I; Iwashita H; Kuroiwa Y
J Neurochem; 1985 Jun; 44(6):1667-71. PubMed ID: 3989556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
